MacroGenics, Inc. Share Price Today: Live Updates & Key Insights
MacroGenics, Inc. share price today is $2.95, up -1.38%. The stock opened at $2.88 against the previous close of $2.9, with an intraday high of $2.9182 and low of $2.81.
MacroGenics, Inc. Share Price Chart
MacroGenics, Inc.
MacroGenics, Inc. Share Price Performance
MacroGenics, Inc. Institutional Holdings
MacroGenics, Inc. Market Status
MacroGenics, Inc. Fundamentals
Market Cap 181.77 M
PB Ratio 3.2698
PE Ratio 0.0
Enterprise Value 28.62 M
Total Assets 256.85 M
Volume 644158
MacroGenics, Inc. Company Financials
About MacroGenics, Inc. & investment objective
Company Information MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
Organisation Biotechnology
Employees 293
Industry Biotechnology
CEO Mr. Eric Blasius Risser
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
MacroGenics, Inc. FAQs
What is the share price of MacroGenics, Inc. today?
The current share price of MacroGenics, Inc. is $2.95.
Can I buy MacroGenics, Inc. shares in India?
Yes, Indian investors can buy MacroGenics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy MacroGenics, Inc. shares in India?
You can easily invest in MacroGenics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy MacroGenics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of MacroGenics, Inc..
Can I buy fractional shares of MacroGenics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of MacroGenics, Inc.?
MacroGenics, Inc. has a market cap of $181.77 M.
In which sector does MacroGenics, Inc. belong?
MacroGenics, Inc. operates in the Biotechnology sector.
What documents are required to invest in MacroGenics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of MacroGenics, Inc.?
The PE ratio of MacroGenics, Inc. is N/A and the PB ratio is 3.27.